Published April 8, 2005 | Version v1
Journal article

α-Actinin-2, a cytoskeletal protein, binds to angiogenin

  • 1. Research Center for Environmental Genomics, Zhejiang University School of Medicine, Hangzhou 310031 (China)
  • 2. Department of Public Health, Zhejiang University School of Medicine, Hangzhou 310031 (China)
  • 3. Research Center for Environmental Genomics, Zhejiang University School of Medicine, Hangzhou 310031 (China) and Department of Public Health, Zhejiang University School of Medicine, Hangzhou 310031 (China)

Description

Angiogenin is an angiogenic factor which is involved in tumorigenesis. However, no particular intracellular protein is known to interact directly with angiogenin. In the present study, we reported the identification of α-actinin-2, an actin-crosslinking protein, as a potential angiogenin-interacting partner by yeast two-hybrid screening. This interaction was confirmed by different approaches. First, angiogenin was pulled down together with His-tagged α-actinin-2 by Ni2+-agarose resins. Second, α-actinin-2 was coimmunoprecipitated with angiogenin by anti-angiogenin monoclonal antibody. Third, the in vivo interaction of these two proteins was revealed by fluorescence resonance energy transfer analysis. Since members of α-actinin family play pivotal roles in cell proliferation, migration, and invasion, the interaction between α-actinin-2 and angiogenin may underline one possible mechanism of angiogenin in angiogenesis. Our finding presents the first evidence of an interaction of a cytosolic protein with angiogenin, which might be a novel interference target for anti-angiogenesis and anti-tumor therapy

Additional details

Identifiers

DOI
10.1016/j.bbrc.2005.01.158;
PII
S0006-291X(05)00232-9;

Publishing Information

Journal Title
Biochemical and Biophysical Research Communications
Journal Volume
329
Journal Issue
2
Journal Page Range
p. 661-667
ISSN
0006-291X
CODEN
BBRCA9

Optional Information

Copyright
Copyright (c) 2005 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.